SEDASYS®, airway, oxygenation, and ventilation: Anticipating and managing the challenges

Basavana Gouda Goudra, Preet Mohinder Singh, Vinay Chandrasekhara

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


In May 2013, the FDA (Federal Drug Administration) approved SEDASYS®, a device that enables non-anesthesia physicians to provide mild-to-moderate sedation to patients undergoing colonoscopy and esophagogastroduodenoscopy. SEDASYS® is the first among the devices being built to provide computer-assisted personalized sedation. Although the intention of this approval is to cut the anesthesia related expenses, it is likely to create new challenges to the users-both clinical and administrative-that might even increase the cost. Deep sedation is required frequently for a successful completion of the procedure, which poses unforeseen challenges. The present review aims to provide clear information to the users regarding pre-procedure assessment, possible sedation related complications and management options.

Original languageEnglish
Pages (from-to)920-927
Number of pages8
JournalDigestive diseases and sciences
Issue number5
StatePublished - May 2014


  • Colonoscopy
  • Esophagogastroduodenoscopy
  • Sedation


Dive into the research topics of 'SEDASYS®, airway, oxygenation, and ventilation: Anticipating and managing the challenges'. Together they form a unique fingerprint.

Cite this